Business Description
Valbiotis SA
ISIN : FR0013254851
Compare
Compare
Traded in other countries / regions
ALVAL.France8JD.Germany IPO Date
2017-06-07Description
Valbiotis SA is a research & development company. It is engaged in scientific innovation for preventing and combating metabolic diseases. Valbiotis has adopted an approach, aiming to revolutionize healthcare by developing a new class of Nutrition Health products designed to reduce the risk of major metabolic diseases, based on a multi-target approach by the use of plant-based ingredients.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.04 | |||||
| Equity-to-Asset | 0.47 | |||||
| Debt-to-Equity | 0.58 | |||||
| Debt-to-EBITDA | -0.81 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 1.31 | |||||
| Beneish M-Score | -2.38 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 60.1 | |||||
| 3-Year EBITDA Growth Rate | -7.4 | |||||
| 3-Year EPS without NRI Growth Rate | -1.2 | |||||
| 3-Year FCF Growth Rate | 5.6 | |||||
| 3-Year Book Growth Rate | -2.1 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 47.7 | |||||
| 9-Day RSI | 50.89 | |||||
| 14-Day RSI | 50.32 | |||||
| 6-1 Month Momentum % | -35.19 | |||||
| 12-1 Month Momentum % | 8.02 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.9 | |||||
| Quick Ratio | 2.79 | |||||
| Cash Ratio | 1.8 | |||||
| Days Inventory | 13612.35 | |||||
| Days Sales Outstanding | 144.94 | |||||
| Days Payable | 30173.33 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -19.9 | |||||
| Shareholder Yield % | -13.96 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 99.61 | |||||
| Operating Margin % | -203.05 | |||||
| Net Margin % | -208.2 | |||||
| FCF Margin % | -228.42 | |||||
| ROE % | -78.47 | |||||
| ROA % | -36.29 | |||||
| ROIC % | -93.3 | |||||
| ROC (Joel Greenblatt) % | -353.62 | |||||
| ROCE % | -51.19 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 11.05 | |||||
| PB Ratio | 4.14 | |||||
| Price-to-Tangible-Book | 4.53 | |||||
| EV-to-EBIT | -6.12 | |||||
| EV-to-EBITDA | -6.58 | |||||
| EV-to-Revenue | 12.42 | |||||
| EV-to-FCF | -5.44 | |||||
| Price-to-Net-Current-Asset-Value | 5.42 | |||||
| Price-to-Net-Cash | 97.5 | |||||
| Earnings Yield (Greenblatt) % | -16.34 | |||||
| FCF Yield % | -16.3 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Valbiotis SA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 4.391 | ||
| EPS (TTM) (€) | -0.85 | ||
| Beta | -0.68 | ||
| Volatility % | 83.35 | ||
| 14-Day RSI | 50.32 | ||
| 14-Day ATR (€) | 0.140228 | ||
| 20-Day SMA (€) | 3.89975 | ||
| 12-1 Month Momentum % | 8.02 | ||
| 52-Week Range (€) | 2.82 - 7.5 | ||
| Shares Outstanding (Mil) | 15.78 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Valbiotis SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Valbiotis SA Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Valbiotis SA Frequently Asked Questions
What is Valbiotis SA(XPAR:ALVAL)'s stock price today?
The current price of XPAR:ALVAL is €3.90. The 52 week high of XPAR:ALVAL is €7.50 and 52 week low is €2.82.
When is next earnings date of Valbiotis SA(XPAR:ALVAL)?
The next earnings date of Valbiotis SA(XPAR:ALVAL) is .
Does Valbiotis SA(XPAR:ALVAL) pay dividends? If so, how much?
Valbiotis SA(XPAR:ALVAL) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers